131 related articles for article (PubMed ID: 19204314)
1. The drug-eluting stent saga.
Windecker S; Jüni P
Circulation; 2009 Feb; 119(5):653-6. PubMed ID: 19204314
[No Abstract] [Full Text] [Related]
2. Peeling-off labels mounting evidence for benefit of drug-eluting stents with off-label use.
Büttner HJ; Neumann FJ
J Am Coll Cardiol; 2007 Nov; 50(21):2037-8. PubMed ID: 18021869
[No Abstract] [Full Text] [Related]
3. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
4. Mounting evidence for safety and improved outcomes of drug-eluting stenting: but is it the stent?
King SB; Hannan EL
Circulation; 2008 Oct; 118(18):1783-4. PubMed ID: 18852362
[No Abstract] [Full Text] [Related]
5. Drug-eluting stents are safe.
Garg S; Serruys P
Clin Pharmacol Ther; 2009 Aug; 86(2):130-2. PubMed ID: 19621006
[No Abstract] [Full Text] [Related]
6. Left main coronary artery stenting: crossing the Rubicon.
Alfonso F
J Am Coll Cardiol; 2009 May; 53(19):1769-72. PubMed ID: 19422983
[No Abstract] [Full Text] [Related]
7. Off-label use of drug-eluting stents putting it in perspective.
Grines CL
J Am Coll Cardiol; 2008 Feb; 51(6):615-7. PubMed ID: 18261679
[No Abstract] [Full Text] [Related]
8. Drug-eluting stent for long coronary artery disease.
Park SJ; Kim YH
Indian Heart J; 2008; 60(6):519-23. PubMed ID: 19276489
[No Abstract] [Full Text] [Related]
9. Management of restenosis in drug-eluting stents: still a challenge!
Gupta M; Kadakia J; Budoff MJ
J Invasive Cardiol; 2010 May; 22(5):220-1. PubMed ID: 20440038
[No Abstract] [Full Text] [Related]
10. Drug-eluting stents in animals and patients: where do we stand today?
Drachman DE
Circulation; 2009 Jul; 120(2):101-3. PubMed ID: 19564555
[No Abstract] [Full Text] [Related]
11. A critical appraisal of the safety and efficacy of drug-eluting stents.
Maluenda G; Lemesle G; Waksman R
Clin Pharmacol Ther; 2009 May; 85(5):474-80. PubMed ID: 19279567
[TBL] [Abstract][Full Text] [Related]
12. Letter by Kereiakes et al regarding article, "Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern".
Kereiakes DJ; Mauri L; Kuntz RE
Circulation; 2007 Oct; 116(16):e389; author reply e390. PubMed ID: 17938296
[No Abstract] [Full Text] [Related]
13. Letter by Agostini et al regarding article, "Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern".
Agostoni P; Sangiorgi GM; Biondi-Zoccai GG
Circulation; 2007 Oct; 116(16):e388; author reply e390. PubMed ID: 17938295
[No Abstract] [Full Text] [Related]
14. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib and hypertension-insights from the effect of celecoxib on restenosis after coronary angioplasty with a taxus stent trial.
Bangalore S; Khianey S; Messerli FH
Am J Cardiol; 2008 Apr; 101(7):1068. PubMed ID: 18359335
[No Abstract] [Full Text] [Related]
16. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).
Fröbert O; Lagerqvist B; Carlsson J; Lindbäck J; Stenestrand U; James SK
J Am Coll Cardiol; 2009 May; 53(18):1660-7. PubMed ID: 19406341
[TBL] [Abstract][Full Text] [Related]
17. Coronary artery restenosis: a paradigm of current treatment approaches.
Kiernan TJ; Kiernan GD; Yan BD
Minerva Cardioangiol; 2009 Feb; 57(1):77-94. PubMed ID: 19202520
[TBL] [Abstract][Full Text] [Related]
18. Drug-eluting stents: limitations of early generation and progress with newer generation devices.
Khattab AA; Windecker S
Minerva Med; 2010 Feb; 101(1):9-23. PubMed ID: 20228717
[TBL] [Abstract][Full Text] [Related]
19. Myocardial Bridge in association with fixed atherosclerotic lesions treated with drug-eluting stents: a follow-up report with quantitative coronary analysis.
Arora P; Bhatia V; Parida AK; Kaul U
Indian Heart J; 2008; 60(6):594-6. PubMed ID: 19276504
[TBL] [Abstract][Full Text] [Related]
20. Vascular brachytherapy revisited for in-stent restenosis in the drug-eluting stent era: current status and future perspective.
Li XJ; Rha SW; Wani SP; Wang L; Poddar KL; Oh DJ
Chin Med J (Engl); 2009 Sep; 122(18):2174-9. PubMed ID: 19781306
[No Abstract] [Full Text] [Related]
[Next] [New Search]
